Novel retinal lesion seen in some ebola survivors

June 15, 2017

(HealthDay)—A small percentage of Ebola virus disease (EVD) survivors have a novel retinal lesion, according to research published in the July issue of the U.S. Centers for Disease Control and Prevention's Emerging Infectious Diseases.

Paul J. Steptoe, M.B.Ch.B., from the University of Liverpool in the United Kingdom, and colleagues conducted a case-control study in Freetown, Sierra Leone, to examine ocular signs in survivors of EVD. Ophthalmic examination, including widefield retinal imaging, was performed in 82 EVD survivors with ocular symptoms and 105 controls from asymptomatic civilian and military personnel and symptomatic eye clinic attendees.

The researchers found that Snellen visual acuity was ≤6/7.5 in 75.6 and 75.5 percent of EVD survivors and controls, respectively. Unilateral white cataracts were seen in 7.4 and 0 percent of EVD survivors and controls, respectively. In two EVD survivors with cataract but no anterior chamber inflammation, the aqueous humor was polymerase chain reaction-negative for Zaire Ebola virus, allowing surgery to be performed. In 14.6 percent of EVD survivors and no controls there was a novel retinal lesion following anatomical distribution of the optic nerve axons.

"We have documented a novel retinal abnormality in EVD survivors that appears to be specific to EVD, although the proportion in the cohort with the condition is small," the authors write.

Explore further: Ebola survivors have a 'unique' retinal scar

More information: Abstract/Full Text

Related Stories

Ebola survivors have a 'unique' retinal scar

May 15, 2017
Researchers from the University of Liverpool have conducted a study of Ebola survivors to determine if the virus has any specific effects on the back on the eye using an ultra widefield retinal camera.

Vision impairment and eye diseases continue to be concerns for Ebola survivors

January 16, 2017
The acute outbreak of Ebola virus disease (EVD) has subsided in West Africa, but the medical community continues to learn about long-term complications for survivors – including the potential for blinding eye disease. One ...

Ebola may leave some survivors blind

May 5, 2016
(HealthDay)—About one-fifth of Ebola survivors in Sierra Leone developed severe or total vision loss within weeks of being declared free of the virus, a new study finds.

Young CA survivors more often have cost-related nonadherence

June 9, 2017
(HealthDay)—Survivors of adolescent and young adult cancer are more likely to report cost-related medication nonadherence, according to a study published online May 23 in Cancer.

Improving treatments for post-Ebola syndrome sufferers

April 12, 2016
Researchers from the University of Liverpool and the King's Sierra Leone Partnership are to present new findings into post-Ebola syndrome at a major European conference this week.

Post-Ebola syndrome in Sierra Leone

February 25, 2016
Researchers from the University's Institute of Translational Medicine have conducted a study of Ebola survivors to describe the medical problems they continue to have after recovering from the acute disease. The results of ...

Recommended for you

Scientists sharpen the edges of cancer chemotherapy with CRISPR

July 13, 2018
Tackling unsolved problems is a cornerstone of scientific research, propelled by the power and promise of new technologies. Indeed, one of the shiniest tools in the biomedical toolkit these days is the genome editing system ...

Looking at the urine and blood may be best in diagnosing myeloma

July 13, 2018
When it comes to diagnosing a condition in which the plasma cells that normally make antibodies to protect us instead become cancerous, it may be better to look at the urine as well as the serum of our blood for answers, ...

Massive genome havoc in breast cancer is revealed

July 12, 2018
In cancer cells, genetic errors wreak havoc. Misspelled genes, as well as structural variations—larger-scale rearrangements of DNA that can encompass large chunks of chromosomes—disturb carefully balanced mechanisms that ...

Study shows biomarker panel boosts lung cancer risk assessment for smokers

July 12, 2018
A four-protein biomarker blood test improves lung cancer risk assessment over existing guidelines that rely solely upon smoking history, capturing risk for people who have ever smoked, not only for heavy smokers, an international ...

Discovering the mechanisms that underlie prostate cancer

July 12, 2018
New research has uncovered insights into the mechanisms that underlie prostate cancer, providing potential targets for new cancer therapies.

New method reveals how well cancer drugs hit their targets

July 12, 2018
Scientists have developed a technique that allows them to measure how well cancer drugs reach their targets inside the body. It shows individual cancer cells in a tumour in real time, revealing which cells interact with the ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.